<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikem.org/w/index.php?action=history&amp;feed=atom&amp;title=Triazolam</id>
	<title>Triazolam - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikem.org/w/index.php?action=history&amp;feed=atom&amp;title=Triazolam"/>
	<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Triazolam&amp;action=history"/>
	<updated>2026-04-17T17:59:16Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.38.2</generator>
	<entry>
		<id>https://wikem.org/w/index.php?title=Triazolam&amp;diff=109829&amp;oldid=prev</id>
		<title>ClaireLewis: Created page with &quot;==Administration== *Type: Benzodiazepine *Dosage Forms: *Routes of Administration: oral *Common Trade Names: Halcion  ==Adult Dosing== *0.25-0.5mg PO qHS  ==Pediatric Dosi...&quot;</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Triazolam&amp;diff=109829&amp;oldid=prev"/>
		<updated>2016-11-09T21:20:57Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;==Administration== *Type: &lt;a href=&quot;/wiki/Benzodiazepine&quot; class=&quot;mw-redirect&quot; title=&quot;Benzodiazepine&quot;&gt;Benzodiazepine&lt;/a&gt; *Dosage Forms: *Routes of Administration: oral *Common Trade Names: Halcion  ==Adult Dosing== *0.25-0.5mg PO qHS  ==Pediatric Dosi...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Página nueva&lt;/b&gt;&lt;/p&gt;&lt;div&gt;==Administration==&lt;br /&gt;
*Type: [[Benzodiazepine]]&lt;br /&gt;
*Dosage Forms:&lt;br /&gt;
*Routes of Administration: oral&lt;br /&gt;
*Common Trade Names: Halcion&lt;br /&gt;
&lt;br /&gt;
==Adult Dosing==&lt;br /&gt;
*0.25-0.5mg PO qHS&lt;br /&gt;
&lt;br /&gt;
==Pediatric Dosing==&lt;br /&gt;
''Safety/efficacy not established''&lt;br /&gt;
&lt;br /&gt;
==Special Populations==&lt;br /&gt;
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]: X&lt;br /&gt;
*[[Lactation risk categories|Lactation risk]]: Infant risk cannot be ruled out&lt;br /&gt;
*Renal dosing: no adjustment&lt;br /&gt;
*Hepatic dosing:  0.125 mg PO qHS&lt;br /&gt;
&lt;br /&gt;
==Contraindications==&lt;br /&gt;
*Allergy to class/drug&lt;br /&gt;
*Concomitant use of potent CYP 3A inhibitors (e.g. itraconazole, ketoconazole, nefazodone, protease-inhibitors)&lt;br /&gt;
*Pregnancy&lt;br /&gt;
&lt;br /&gt;
==Adverse Reactions==&lt;br /&gt;
===Serious===&lt;br /&gt;
*Respiratory depression, apnea&lt;br /&gt;
*Liver failure, cholestatic jaundice syndrome&lt;br /&gt;
*Amnesia, abnormal behavior, worsening depression, suicidal thoughts&lt;br /&gt;
*Dystonia&lt;br /&gt;
*Paradoxical excitability&lt;br /&gt;
*Drug dependence, withdrawal&lt;br /&gt;
===Common===&lt;br /&gt;
*Somnolence&lt;br /&gt;
*Dizziness, lightheadedness&lt;br /&gt;
*Nervousness&lt;br /&gt;
*Headache&lt;br /&gt;
&lt;br /&gt;
==Pharmacology==&lt;br /&gt;
*Half-life: 1.5-5h&lt;br /&gt;
*Metabolism: Hepatic, via CYP3A&lt;br /&gt;
*Excretion: Renal&lt;br /&gt;
&lt;br /&gt;
==Mechanism of Action==&lt;br /&gt;
*Triazolobenzodiazepine, GABA-receptor agonist&lt;br /&gt;
&lt;br /&gt;
==Comments==&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
*[[Benzodiazepines]]&lt;br /&gt;
*[[Benzodiazepine withdrawal]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
[[Category:Pharmacology]]&lt;/div&gt;</summary>
		<author><name>ClaireLewis</name></author>
	</entry>
</feed>